Sodium-glucose cotransporter-2 (SGLT2) inhibitors lower blood sugar levels and have additional beneficial effects on kidney and heart health for individuals with and without diabetes, but little is known about the safety and efficacy of these medications in kidney transplant recipients. Research that examined…
in Health
Real-world analysis of sodium-glucose cotransporter-2 inhibitors in kidney transplant recipients
